Price TargetDecreasing price target to $1.00 reflects updated adoption assumptions for protein sequencing.
Product AdoptionPlacements of QSI's Platinum protein sequencer were modestly below expectations.
Risk FactorsRisks include clinical, technology, regulatory, manufacturing, commercial, legal and intellectual property, competition, and dilution.